metricas
covid
Buscar en
Gastroenterología y Hepatología
Toda la web
Inicio Gastroenterología y Hepatología Tumor carcinoide hepático único en un paciente tratado por adenocarcinoma de r...
Journal Information
Vol. 27. Issue 3.
Pages 125-128 (January 2004)
Share
Share
Download PDF
More article options
Vol. 27. Issue 3.
Pages 125-128 (January 2004)
Full text access
Tumor carcinoide hepático único en un paciente tratado por adenocarcinoma de recto. Crecimiento rápido sin síndrome carcinoide
Solitary hepatic carcinoid tumor in a man with prior treatment for rectal adenocarcinoma. Rapid growth without carcinoid syndrome
Visits
4207
M. Iribarren Díaz
Corresponding author
iribarren.diaz@cmpont.es

Correspondencia: Servicio de Cirugía General y Aparato Digestivo. Complejo Hospitalario Xeral-Cíes. Avda. Pizarro, 22. 36204 Vigo. Pontevedra. España.
, G. de Castro Parga, G. Freiría Barreiro, R. Fernández Martín, R. Meléndez Villar, H. Piñeiro Martínez, P. Gil Gil
Servicio de Cirugía General y Aparato Digestivo. Complejo Hospitalario Xeral-Cíes. Vigo. Pontevedra. España
This item has received
Article information
Resumen

Se describe un caso de tumor carcinoide hepático diagnosticado tras la realización de hepatectomía derecha y considerado inicialmente como metástasis de un adenocarcinoma rectal intervenido 7 años antes. Destacamos la localización hepática única, el gran volumen tumoral, el rápido crecimiento y la ausencia de síndrome carcinoide. Se presentan los estudios de diagnóstico funcional y de localización, donde destaca la ausencia de neoplasia en otras localizaciones, motivo por el cual consideramos este tumor como probable tumor carcinoide hepático primario.

La asociación de tumores carcinoides con otras neoplasias es bien conocida pero, dados los antecedentes de nuestro paciente y la ausencia de sintomatología, el diagnóstico preoperatorio resultó incorrecto y sólo la anatomía patológica confirmó el diagnóstico definitivo, lo que permitió poner en marcha los estudios de función y localización específicos, así como adoptar las medidas terapéuticas y de control evolutivo que se consideraron adecuadas.

Aunque la cirugía desempeña un papel fundamental en el tratamiento de estos tumores, debe enmarcarse dentro del abordaje multidisciplinario recomendado para esta patología.

We describe a case of hepatic carcinoid tumor that was diagnosed after right hepatectomy. The tumor was initially believed to be metastases from a rectal adenocarcinoma for which surgery had been performed seven years earlier.

We highlight the localization of the tumor in the liver only, its large size and rapid growth, as well as the absence of carcinoid syndrome. Diagnostic studies of function and localization are presented. The absence of neoplasia in other locations suggested that this neoplasm was probably a primary hepatic carcinoid tumor.

The association of carcinoid tumors with other neoplasms is well-known. However, because of our patient's history and the absence of symptoms, the preoperative diagnosis was incorrect. The definitive diagnosis was confirmed by pathological analysis, allowing specific studies of function and localization to be performed and therapeutic and follow-up measures to be adopted.

Although surgery plays a crucial role in the treatment of these tumors, it should be performed in the context of the multidisciplinary management recommended for this disease.

Full text is only aviable in PDF
Biblografía
[1.]
M.K. McStay, M.E. Caplin.
Carcinoid tumour.
Minerva Med, 93 (2002), pp. 341-389
[2.]
J. Lai, C. Ch'ng, J. Polak, S. Bloom.
Endocrine aspects of liver tumours.
Surgery of the liver and biliary tract, pp. 1191-1199
[3.]
Z.S. Rassi, L. Ferdinand, R.M. Mohsine, F. Berger, C. Lombard-Bohas, O. Boillot, et al.
Primary and secondary liver endocrine tumors: clinical presentation, surgical approach and outcome.
Hepatogastroenterol, 49 (2002), pp. 1340-1346
[4.]
J. Banzo, M.D. Abos, E. Prats, F. García, E. Freile, P. Razola, et al.
Tumor carcinoide bronquial y gammagrafía de receptores de somatostatina: detección de metástasis óseas.
Rev Esp Med Nucl, 20 (2001), pp. 431-438
[5.]
S. Sonnet, W. Wiesner.
Flush symptoms caused by mesenteric carcinoid without liver metastases.
JBR-BTR, 85 (2002), pp. 254-256
[6.]
M.E. Caplin, J.R. Buscombe, A.J. Hilson, A.L. Jones, A.F. Watkinson, A.K. Burroughs.
Carcinoid tumour.
[7.]
J.L. Pasieka, J.G. McKinnon, S. Kinnear, C.A. Yelle, L. Numerow, A. Paterson, et al.
Carcinoid syndrome symposium on treatment modalities for gastrointestinal carcinoid tumours: symposium summary.
Can J Surg, 44 (2001), pp. 25-32
[8.]
K.A. Yao, M.S. Talamonti, A. Nemcek, P. Angelos, H. Chrisman, J. Skarda, et al.
Indication and results of liver resection and hepatic chemoembolization for metastatic gastrointestinal neuroendocrine tumors.
Surgery, 130 (2001), pp. 677-685
[9.]
H. De Vries, R.C. Verschueren, P.H. Willemse, I.P. Kema, E.G. De Vries.
Diagnostic, surgical and medical aspect of the midgut carcinoids.
Cancer Treat Rev, 28 (2002), pp. 11-25
[10.]
T. Roth, A. Marmorale, A. Gavelli, C. Huguet.
The surgical treatment of liver metastasis of carcinoid tumors.
Ann Chir, 127 (2002), pp. 783-785
[11.]
M. Iwao, M. Nakamuta, M. Enjoji, H. Kubo, T. Fukutomi, Y. Tanabe, et al.
Primary hepatic carcinoid tumor: case report and review o 53 cases.
Med Sci Monit, 7 (2001), pp. 746-750
[12.]
J. Banzo, M.D. Abos, E. Prats, M. Delgado, P. Razola, S. García, et al.
La gammagrafía de receptores de somatostatina en el tumor carcinoide.
Rev Esp Med Nucl, 20 (2001), pp. 11-18
[13.]
R.A. Valdés Olmos, C.A. Hoefnagel, E. Bais, H. Boot, B. Taal, J. De Kraker, et al.
Avances terapéuticos de medicina nuclear en oncología.
Rev Esp Med Nucl, 20 (2001), pp. 547-557
[14.]
H.J. Wester, M. Schottelius, K. Scheidhauer, J.C. Reubi, M. Schwaiger.
Comparison of radioiodinated TOC. TOCA and Mtr-TOCA: the effect of carbohydratation on the pharmacokinetics.
Eur J Nucl Med Mol Imaging, 29 (2002), pp. 28-38
[15.]
L. Berna Roqueta, J.C. Martín Marimón, J. Martín Martínez.
Gammagrafía con receptores de somatostatina en un caso de tumor carcinoide recurrente. Importancia de la detección tomográfica.
Rev Esp Med Nucl, 21 (2002), pp. 123-124
[16.]
C. Le Rest, J.B. Bomanji, D.C. Costa, C.E. Townsend, D. Visvikis, P.J. Ell.
Functional imaging of malignant paragangliomas and carcinoid tumours.
Eur J Nucl Med, 28 (2001), pp. 478-482
[17.]
H.J. Wester, M. Schottelius, K. Scheidhauer, G. Meisetschlager, M. Herz, F.C. Rau, et al.
PET imaging of somatostatin receptors: design, synthesis and preclinical evaluation of a novel(18)F-labelled, carbohydrated analogue of octreotide.
Eur J Nucl Med Mol Imaging, 30 (2003), pp. 117-122
[18.]
E. Berber, N. Flesher, A.E. Siperstein.
Laparoscopic radiofrequency ablation of neuroendocrine liver metastases.
World J Surg, 26 (2002), pp. 985-990
[19.]
W.L. Leong, J.L. Pasieka.
Regression of metastatic carcinoid tumors with octreotide therapy: two case reports and a review of the literature.
J Surg Oncol, 79 (2002), pp. 180-187
[20.]
S. Ricci, A. Antonuzzo, L. Galli, M. Ferdeghini, L. Bodei, C. Orlandini, et al.
Octreotide acetate long-acting release in patients with metastatic tumors pretreated with lanreotide.
Ann Oncol, 11 (2000), pp. 1127-1130
[21.]
P.F. Quaedvlieg, C.B. Lamers, B.G. Taal.
Carcinoid heart disease: an update.
Scand J Gastroenterol Suppl, 236 (2002), pp. 66-71
[22.]
M. Cybulla, S.M. Weiner, A. Otte.
End-stage renal disease after treatment with 90-DOTATOC. Coment.
Eur J Nucl Med, 28 (2001), pp. 1552-1554
[23.]
M.H. Chung, J. Pisegna, M. Spirt, A.E. Giuliano, W. Ye, K.P. Ramming, et al.
Hepatic cytoreduction followed by a novel long-acting somatostatin analog: a paradigm for intractable neuroendocrine tumors metastatic to the liver.
Surgery, 130 (2001), pp. 954-962
[24.]
M. Schindl, K. Kaczirek, C. Passler, K. Kaserer, G. Prager, C. Scheuba, et al.
Treatment of small intestinal neuroendocrine tumors: is an extended multimodal approach justified?.
World J Surg, 26 (2002), pp. 976-984
[25.]
S.A. Gulec, T.S. Mountcastle, D. Frey, J.D. Cundiff, E. Mathews, L. Anthony, et al.
Cytoreductive surgery in patients with advanced-stage carcinoid tumors.
Am J Surg, 68 (2002), pp. 667-671
[26.]
H.A. Kharrat, H. Taubin.
Carcinoid crisis induced by external manipulation of the liver metastases.
J Clin Gastroenterol, 36 (2003), pp. 87-88
[27.]
C. Erce, R.W. Parks, D. Casanova.
Técnicas intersticiales para la destrucción de tumores hepáticos.
Cir Esp, 72 (2002), pp. 273-286
[28.]
H. Nave, E. Mossinger, H. Feist, H. Lang, H. Raab.
Surgery as primary treatment in patients with liver metastases from carcinoid tumors: a retrospective, unicentric study over 13 years.
Surgery, 129 (2001), pp. 170-175
[29.]
P. Hellman, S. Ladjevardi, B. Skogseid, G. Akerstrom, A. Elvin.
Radiofrequency tissue ablation using cooled tip for liver metastases of endocrine tumors.
World J Surg, 26 (2002), pp. 1052-1056
Copyright © 2004. Elsevier España, S.L.. Todos los derechos reservados
Download PDF
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos